Consumer Staples

Clorox forecasts drop in annual sales as pandemic boom fades

Share
Key Points
  • Clorox on Tuesday signaled that the pandemic-driven boom in demand for its bleaches, wipes and other surface cleaners was receding due to vaccinations and easing of Covid-19 curbs.
  • The company forecast fiscal 2022 sales to fall between 2% and 6%, while analysts expected a decline of 1%, according to Refinitiv IBES data.
  • Clorox's results also took a hit from rising costs of raw materials, such as pulp, resin and petrochemical products, that have prompted companies across sectors to increase prices.

In this article

VIDEO2:2002:20
Jim Cramer on Clorox earnings report: It is very disappointing

Clorox on Tuesday signaled that the pandemic-driven boom in demand for its bleaches, wipes and other surface cleaners was receding due to vaccinations and easing of Covid-19 curbs.

The company forecast fiscal 2022 sales to fall between 2% and 6%, while analysts expected a decline of 1%, according to Refinitiv IBES data.

Like Procter & Gamble and Britain's Reckitt Benckiser Group, Clorox had benefited from consumers stockpiling cleaning products at the height of the pandemic last year.

But with the opening up of the economy, sales in its mainstay health and wellness unit slumped 17% in the fourth quarter. The household business, which makes Glad trash bags and Kingston charcoal, reported an 8% drop in sales.

"This was a poor quarter," said Edward Jones analyst John Boylan. He added that while the brokerage expected the first half to be difficult due to tough year-ago comparables, normalization of sales and profit would take longer than its initial estimations.

Clorox's results also took a hit from rising costs of raw materials, such as pulp, resin and petrochemical products, that have prompted companies across sectors to increase prices.

Despite a price hike earlier in 2021, its gross margins declined by 970 basis points to 37.1%. That, in part, pulled down its adjusted earnings to 95 cents per share, which missed expectations of $1.35 per share.

Total net sales fell to $1.80 billion from $1.98 billion, falling short of estimates of $1.92 billion.